Drug Type Small molecule drug |
Synonyms Candesartan cilexetil/pioglitazone, TCV-116/pioglitozone |
Target |
Action antagonists, agonists |
Mechanism AT1R antagonists(Angiotensin II Receptor Type 1 antagonists), PPARγ agonists(Peroxisome proliferator-activated receptor γ agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC33H34N6O6 |
InChIKeyGHOSNRCGJFBJIB-UHFFFAOYSA-N |
CAS Registry145040-37-5 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetes Mellitus, Type 2 | Phase 3 | - | - | |
| Hypertension | Phase 3 | Japan | - |





